logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Jaime R. Merchan

Sarah Cannon Research Institute
H指数:40
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

EV-103 dose escalation/cohort A: 5-year follow-up of enfortumab vedotin plus pembrolizumab in previously untreated locally advanced/metastatic urothelial carcinoma

EV-103剂量递增/队列A：恩沃利单抗 vedotin 联合帕博利珠单抗治疗既往未治疗的局部晚期/转移性尿路上皮癌的5年随访

ESMO Open
IF8.3
2026-05-190
OAAI
J.E. Rosenberg; P.H. O'Donnell; D.P. Petrylak; T.W. Flaig; C.J. Hoimes; S. Gupta; N. Mar; T.W. Friedlander; S.T. Tagawa; M.A. Bilen; J.R. Brown; R.R. McKay; J.R. Merchan; S. Srinivas; S. Gorla; B.H. Moreno; G. Davis; H.S. Wirtz; Y. Zhu; M.I. Milowsky
Metabolomic Insights Into Saliva as a Non-Invasive Surrogate for Serum to Enable Community-Based Biomarker Investigation

唾液代谢组学洞察：作为血清非侵入性替代品以实现社区基础生物标志物研究

Prostate
IF2.5
2026-02-010
OAAI
Abdshah, Alireza; Alyamani, Mohammad; Burgess, Robert A.; Parekh, Dipen J.; Spieler, Benjamin; Singal, Rakesh; Abramowitz, Matthew C.; Merchan, Jaime R.; Pannunzio, Lucia; Mahal, Brandon A.; Kobetz, Erin; Punnen, Sanoj; Bilusic, Marijo; Sharifi, Nima
MDX-2001-101 study protocol: a phase I/IIa, multicenter, first-in-human, open-label clinical trial evaluating MDX2001 monotherapy in patients with advanced solid tumors

MDX-2001-101研究方案：一项评估MDX2001单药治疗在晚期实体瘤患者中的I/IIa期、多中心、首次人体、开放标签临床试验

Future Oncology
IF2.6
2026-01-010
OA
Dumbrava, Ecaterina; Minchom, Anna; Henry, Jason; Johnson, Melissa; Sommerhalder, David; Merchan, Jaime; Heist, Rebecca; Cabanas, Elena Garralda; Cotreau, Monette; Goenaga, Anne-Laure; Burzyn, Dalia; Makris, Lukas; Culm, Kerry; Abbadessa, Giovanni
Combination casdatifan plus cabozantinib in previously treated patients with clear cell renal cell carcinoma: results from an expansion cohort of ARC-20 (NCT05536141)

联合卡达提法尼和卡博扎替尼用于既往治疗过的透明细胞肾细胞癌患者的方案：ARC-20（NCT05536141）扩展队列的研究结果

ONCOLOGIST
IF4.2
2025-10-010
OAAI
Choueri, Toni; Ornstein, Moshe; Barata, Pedro C.; Matrana, Marc; Merchan, Jaime; Gedye, Craig; Hwang, Clara; Kumar, Rohit; Lee, Jae Lyun; Guan, Yinghui; Ghasemi, Mohammad; Quadri, Syed; Negro, Chris; Chen, Jianfen; Foster, Paul; Warad, Deepti; McGregor, Bradley A.; Rha, Sun Young; Drakaki, Alexandra
Safety, Tumor Homing And Immune Effects Of Systemically Administered Vocimagene Amiretrorepvec In Patients With Advanced Solid Tumors: A Phase 1B Study

安全性、肿瘤归巢及免疫效应：系统性给予vocimagene amiretrorepvec治疗晚期实体瘤患者的1B期研究

Molecular Therapy
IF12
2025-08-210
OAAI
Jaime R. Merchan; Jordi Rodon; Shree Venkat; Arthur Donahue; Amber Thomassen; William P. Accomando; Maria Rodriguez-Aguirre; Deukwoo Kwon; Cornelia Bentley; Daniel J. Hogan; Olivia Roos Rodrigues; Sharon Yavrom; Derek Ostertag; Jolene Shorr; Gerald S. Falchook
Study EV-103 dose escalation/cohort A (DE/A): 5y follow-up of first-line (1L) enfortumab vedotin (EV) plus pembrolizumab (P) in cisplatin (CIS)-ineligible locally advanced or metastatic urothelial carcinoma (la/mUC)

研究EV-103剂量递增/队列A（DE/A）：在不可接受顺铂治疗的局部晚期或转移性尿路上皮癌（la/mUC）中，恩沃利单抗偶联物（EV）联合帕博利珠单抗（P）的一线（1L）5年随访研究

ANNALS OF ONCOLOGY
IF65.4
2024-09-012
PRE
Rosenberg, J. E.; Petrylak, D. P.; Flaig, T.; Hoimes, C. J.; Gupta, S.; O'Donnell, P. H.; Mar, N.; Friedlander, T.; Tagawa, S. T.; Bilen, M. A.; Brown, J. R.; McKay, R. R.; Merchan, J. R.; Srinivas, S.; Shetty, A.; Homet Moreno, B.; Davis, G.; Wirtz, H.; Zhu, Y.; Milowsky, M. I.
Oncolytic virus CF33-hNIS for the treatment of advanced cancer
CANCER RESEARCH
IF16.6
2024-04-050
PRE
Li, Daneng; Shields, Anthony F.; Mamdani, Hirva; Travis, Patrick; Wright, Gavin; Akerley, Wallace; Spira, Alex; Daniels, Gregory; Merchan, Jaime; Kumar, Abhijeet; Lim, Emerson; Egelston, Colt; Flores, Oscar; Hamilton, Stanley; Austria, Janet; Seiz, Amanda; Yavrom, Sharon; Fein, Seymour; Byon, John; Woodard, Paul; Wilkinson, Grey A.; Leddon, Jennifer
Phase I LITESPARK-001 study of belzutifan for advanced solid tumors: Extended 41-month follow-up in the clear cell renal cell carcinoma cohort

Beztifan治疗晚期实体瘤的I期LITESPARK-001研究: 在透明细胞肾细胞癌队列中延长41个月的随访

EUROPEAN JOURNAL OF CANCER
IF7.1
2024-01-017
PRE
Jonasch, Eric; Bauer, Todd M.; Papadopoulos, Kyriakos P.; Plimack, Elizabeth R.; Merchan, Jaime R.; Mcdermott, David F.; Michaelson, M. Dror; Appleman, Leonard J.; Roy, Ananya; Perini, Rodolfo F.; Liu, Yanfang; Choueiri, Toni K.
A plain language summary exploring a new treatment combination for untreated locally advanced or metastatic urothelial cancer: enfortumab vedotin plus pembrolizumab

探索未经治疗的局部晚期或转移性尿路上皮癌的新治疗组合: enfortumab vedotin加pembrolizumab

FUTURE ONCOLOGY
IF2.6
2023-11-230
OAAI
Hoimes, Christopher J.; Flaig, Thomas W.; Milowsky, Matthew, I; Friedlander, Terence W.; Bilen, Mehmet Asim; Gupta, Shilpa; Srinivas, Sandy; Merchan, Jaime R.; Mckay, Rana R.; Petrylak, Daniel P.; Sasse, Carolyn; Moreno, Blanca Homet; Yu, Yao; Carret, Anne-Sophie; Rosenberg, Jonathan E.
Pexa-vec (thymidine kinase-deactivated vaccinia virus plus GM-CSF) in combination with cemiplimab (REGN2810; ANTIPD-1) for metastatic or unresectable renal cell carcinoma REN026: Results from a phase II study
ANNALS OF ONCOLOGY
IF65.4
2023-10-011
OAAI
Rha, S. Y.; Bae, W. K.; Kim, C.; Oh, S. Y.; Lee, H. W.; Park, K.; Mar, N.; Kichenadasse, G.; Ha, H. K.; Pachynski, R.; Park, I.; Park, K. H.; Kim, S. H.; Folefac, E.; Mathias, M. D.; Seebach, F.; Ma, S.; Carranza, L.; Beom, S-H.; Merchan, J. R.

研究方向

暂未获取到该数据
Y
Yuqi Jing
H 指数:9论文数:89被引数:352
V
Valery Chávez
H 指数:5论文数:52被引数:141
K
Krisztina Kovács
H 指数:5论文数:34被引数:232
T
Toni K. Choueiri
H 指数:149论文数:2,479被引数:12.7万
D
David F. McDermott
H 指数:109论文数:1,058被引数:8.8万
S
Sun Young Rha
H 指数:86论文数:1,323被引数:3.4万
M
M. Dror Michaelson
H 指数:65论文数:284被引数:2.8万
S
Stephen J. Russell
H 指数:106论文数:854被引数:4.3万
A
Afonso Ribeiro
H 指数:23论文数:89被引数:1,884
R
Rodolfo F. Perini
H 指数:36论文数:234被引数:1.5万